Viking Therapeutics (VKTX) Q2 2026 Earnings

Apr 29Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.38
-1.07
-0.76
-0.45

Details

Expected EPS
-0.975576
Actual EPS
-1.37
Surprise EPS
-0.39
Surprise Percent
-40.43%

Description

⁨Viking Therapeutics⁩ (⁦VKTX⁩) has reported earnings of ⁦-1.37⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts